Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A

Show other versions (2)

Objective: To evaluate the outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine as first-line treatment at this institution. Methods: Retrospective analysis of 26 pediatric patients with aplastic anemia, treated between 1996 and 2011 wi...

Full description

Bibliographic Details
Main Authors:	Marlene Pereira Garanito, Jorge David Aivazoglou Carneiro, Vicente Odone Filho, Phillip Scheinberg
Format:	Article
Language:	English
Published:	Elsevier 2014-09-01
Series:	Jornal de Pediatria
Online Access:	http://www.sciencedirect.com/science/article/pii/S0021755714000655

Similar Items

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A,
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Acquired severe aplastic anemia treated with antithymocyte globulin and cyclosporine: An experience of regional cancer center, Western India
by: Ankit B Patel, et al.
Published: (2015-01-01)

Successful Desensitization of a Patient with Aplastic Anemia to Antithymocyte Globulin
by: Stephanie A. Wolanin M.D., et al.
Published: (2015-03-01)

Response to the second cycle of immunosuppressive therapy (antithymocyte globulin)in children with aplastic anemia
by: Rupamon Nongbet, et al.
Published: (2022-01-01)

Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin
by: de-Medeiros C.R., et al.
Published: (2000-01-01)

Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience.
by: Xingxin Li, et al.
Published: (2013-01-01)

Current management of severe acquired aplastic anemia
by: Phillip Scheinberg
Published: (2011-06-01)

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia
by: Margherita Vieri, et al.
Published: (2023-06-01)

An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia
by: Lixian Chang, et al.
Published: (2023-07-01)

A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia
by: L.V.M. Ommati, et al.
Published: (2009-03-01)

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
by: Namita Singh, MD, et al.
Published: (2018-02-01)

Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia
by: Małgorzata Salamonowicz-Bodzioch, et al.
Published: (2021-09-01)

Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
by: Ruixin Li, et al.
Published: (2022-05-01)

Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant Patients
by: Grace Pui-Yun Lee, PharmD, BCCCP, et al.
Published: (2022-06-01)

Population Pharmacokinetics of Cyclosporine in Chinese Pediatric Patients With Acquired Aplastic Anemia
by: Xuan Gao, et al.
Published: (2022-07-01)

Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C
by: R. F. Saidi, et al.
Published: (2011-10-01)

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report
by: Yohan Park, et al.
Published: (2020-07-01)

P793: EFFICACY AND IN VIVO EFFECTS OF PORCINE ANTIHUMAN LYMPHOCYTE IMMUNOGLOBULIN COMPARED TO RABBIT ANTITHYMOCYTE IMMUNOGLOBULIN IN SEVERE APLASTIC ANEMIA
by: Guangsheng He, et al.
Published: (2023-08-01)

B-cell-rich T-cell lymphoma associated with Epstein-Barr virus-reactivation and T-cell suppression following antithymocyte globulin therapy in a patient with severe aplastic anemia
by: Nobuyoshi Hanaoka, et al.
Published: (2015-09-01)

Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application
by: A D Kulagin, et al.
Published: (2010-07-01)

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
by: Shamim Rafat, et al.
Published: (2017-01-01)

Severe Acute Interstitial Nephritis: Response to Therapy With Antithymocyte Globulin
by: Tiffany Shao, et al.
Published: (2017-03-01)

Retrospective Comparison of Efficacy and Safety of Rabbit Anti-Thymocyte Globulin and Porcine Anti-Lymphocyte Globulin in Patients With Acquired Aplastic Anemia Undergoing Hematopoietic Stem Cell Transplantation From Matched Sibling Donors
by: Yuanfeng Zhang, et al.
Published: (2022-06-01)

Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity.
by: Diana Stauch, et al.
Published: (2009-01-01)

Novel therapeutic choices in immune aplastic anemia [version 1; peer review: 2 approved]
by: Phillip Scheinberg
Published: (2020-09-01)

Bilateral femoral head osteonecrosis due to cyclosporine therapy in aplastic anemia
by: Mansoor C Abdulla, et al.
Published: (2018-01-01)

Effective treatment of aplastic anemia secondary to chemoradiotherapy using cyclosporine A
by: Jing Ruan, et al.
Published: (2021-10-01)

Cyclosporine monotherapy for severe aplastic anemia : A developing country experience.
by: Al-Ghazaly Jameel, et al.
Published: (2005-01-01)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
by: Rachel Jeong, et al.
Published: (2020-10-01)

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
by: Yıldız Yıldırmak, et al.
Published: (2012-05-01)

Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
by: Ziqi Wan, et al.
Published: (2023-05-01)

Gingival and lip hypertrophy induced by cyclosporin A treatment in an aplastic anemia patient
by: Illias Tazi
Published: (2009-06-01)

Second haploidentical bone marrow transplantation with antithymocyte antibody-containing conditioning regimen for graft failure in eight patients with severe aplastic anemia
by: Chengtao Zhang, et al.
Published: (2024-01-01)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
by: G. R. Pourmand, et al.
Published: (2012-04-01)

Role of antithymocyte globulin in reducing the incidence of complications after allogeneic hemopoietic cell transplantation
by: Yu R Zalyalov, et al.
Published: (2010-08-01)

THPO gene variants in patients with acquired aplastic anemia
by: Pedro Henrique Padilha, et al.
Published: (2018-10-01)

Acquired aplastic anemia in childhood: single-center experience
by: M. Bilici, et al.
Published: (2020-10-01)

Aplasia medular após transplante hepático em pediatria Aplastic anemia after pediatric liver transplantation
by: Marlene P. Garanito, et al.
Published: (2009-01-01)

Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
by: Isa F. Ashoor, MD, et al.
Published: (2020-09-01)